Presentation is loading. Please wait.

Presentation is loading. Please wait.

FIGURE 3 Adipose tissue mRNA expression of CDO1 (A), BCAT1 (B), and BCKDHA (C) in a subset (n = 20) of the total ... FIGURE 3 Adipose tissue mRNA expression.

Published byΜαρία Κεδίκογλου Modified over 5 years ago

Similar presentations

Presentation on theme: "FIGURE 3 Adipose tissue mRNA expression of CDO1 (A), BCAT1 (B), and BCKDHA (C) in a subset (n = 20) of the total ... FIGURE 3 Adipose tissue mRNA expression."— Presentation transcript:

1 FIGURE 3 Adipose tissue mRNA expression of CDO1 (A), BCAT1 (B), and BCKDHA (C) in a subset (n = 20) of the total ... FIGURE 3 Adipose tissue mRNA expression of CDO1 (A), BCAT1 (B), and BCKDHA (C) in a subset (n = 20) of the total population (left side of panel) and separately (right side of panel) in low fat gainers (n = 10; fat gain <1.95 kg/28 d) compared with high fat gainers (n = 10; fat gain ≥1.95 kg/28 d) at baseline (day 0) and after 28 d of food overconsumption. Values are means ± SEMs, calculated by linear mixed models with the use of log-transformed data. P values are for the effect of time in the total population and for the time × fat gain interaction. *Different from day 0, P < 0.05. BCAT1, branched-chain aminotransferase-1; BCKDHA, branched-chain keto acid dehydrogenase E1α polypeptide; CDO1, cysteine dioxygenase-1. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2018 American Society for Nutrition.This article is published and distributed under the term of oxford University Press, standard Journals Publication Model ( J Nutr, Volume 148, Issue 7, 13 June 2018, Pages 1073–1080, The content of this slide may be subject to copyright: please see the slide notes for details.

2 FIGURE 2 Fasting serum BCAAs (A–C) and aromatic amino acids (D–F) at baseline (day 0) and after 3 and 28 d of food ... FIGURE 2 Fasting serum BCAAs (A–C) and aromatic amino acids (D–F) at baseline (day 0) and after 3 and 28 d of food overconsumption in healthy adults. Values are means ± SEMs. P values are for the effect of time in the total population (n = 40) and for the time × fat gain interaction. Where P-interaction is <0.1, insets depict amino acid changes separately for low fat gainers (n = 18; fat gain <1.95 kg/28 d) and high fat gainers (n = 19; fat gain ≥1.95 kg/28 d). Labeled means without a common letter differ, P < 0.05. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2018 American Society for Nutrition.This article is published and distributed under the term of oxford University Press, standard Journals Publication Model ( J Nutr, Volume 148, Issue 7, 13 June 2018, Pages 1073–1080, The content of this slide may be subject to copyright: please see the slide notes for details.

3 FIGURE 1 Fasting serum sulfur-containing amino acids (A–E) and tGSH (F) at baseline (day 0) and after 3 and 28 d of ... FIGURE 1 Fasting serum sulfur-containing amino acids (A–E) and tGSH (F) at baseline (day 0) and after 3 and 28 d of food overconsumption in healthy adults. Values are means ± SEMs. P values are for the effect of time in the total population (n = 40) and the time × fat gain interaction. Where P-interaction is <0.1, insets depict amino acid changes separately for low fat gainers (n = 18; fat gain <1.95 kg/28 d) and high fat gainers (n = 19; fat gain ≥1.95 kg/28 d). Labeled means without a common letter differ, P < 0.05. tCys, total cysteine; tGSH, total glutathione; tHcy, total homocysteine. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2018 American Society for Nutrition.This article is published and distributed under the term of oxford University Press, standard Journals Publication Model ( J Nutr, Volume 148, Issue 7, 13 June 2018, Pages 1073–1080, The content of this slide may be subject to copyright: please see the slide notes for details.

4 FIGURE 4 Percentage change in serum amino acid concentrations in the total population in response to insulin infusion ... FIGURE 4 Percentage change in serum amino acid concentrations in the total population in response to insulin infusion at baseline (day 0) and after 28 d of food overconsumption. Values are means ± SEMs, n = 40. *Pre- and postinsulin amino acid concentrations at the specified time point (day 0 or 28) differ by paired-samples t test, P < 0.05; <sup>#</sup>amino acid percentage change differs from day 0 by paired-samples t test, P < 0.05. Cysta, cystathionine; tCys, total cysteine; tGSH, total glutathione; tHcy, total homocysteine. Unless provided in the caption above, the following copyright applies to the content of this slide: © 2018 American Society for Nutrition.This article is published and distributed under the term of oxford University Press, standard Journals Publication Model ( J Nutr, Volume 148, Issue 7, 13 June 2018, Pages 1073–1080, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "FIGURE 3 Adipose tissue mRNA expression of CDO1 (A), BCAT1 (B), and BCKDHA (C) in a subset (n = 20) of the total ... FIGURE 3 Adipose tissue mRNA expression."

Similar presentations

FIGURE 1 Schematic of stable-isotope infusion studies performed for the measurement of BCAA and FFA kinetics. In study protocol 1, BCAA kinetics in 14.

FIGURE 1 Schematic of stable-isotope infusion studies performed for the measurement of BCAA and FFA kinetics. In study protocol 1, BCAA kinetics in 14.
Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Data-selection process

Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Flow diagram detailing the systematic review process.
Figure 1 Schematic representation of the experimental design.

Figure 1 Schematic representation of the experimental design.
Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1 Mechanism of mortality benefit associated with radial access
Figure 1 Number of percutaneous coronary interventions (PCI) in mainland China, 2017 (total 753 142). Data from China ... Figure 1 Number of percutaneous.

Figure 1 Number of percutaneous coronary interventions (PCI) in mainland China, 2017 (total 753 142). Data from China ... Figure 1 Number of percutaneous.
FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients.

FIGURE 1 Percentage of patients with sarcopenia or low SMD across the spectrum of total adiposity (N = 3262). SMD, ... FIGURE 1 Percentage of patients.
Fig. 1. Relative potency ratios of 13 active ingredients used against a fall armyworm population collected in Puerto ... Fig. 1. Relative potency ratios.

Fig. 1. Relative potency ratios of 13 active ingredients used against a fall armyworm population collected in Puerto ... Fig. 1. Relative potency ratios.
FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.

FIGURE 1 Patient enrolment flowchart. SBS, short bowel syndrome.
Figure 1 Phases of the research. Author’s own work.

Figure 1 Phases of the research. Author’s own work.
FIGURE 1 Flowchart of the study population.

FIGURE 1 Flowchart of the study population.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.
AHA: American Heart Association; ALT: ...

AHA: American Heart Association; ALT: ...
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Source: Figure created by the author based on data ...

Source: Figure created by the author based on data ...
Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.

Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.
RCTs: randomized controlled ...

RCTs: randomized controlled ...

Similar presentations

Ads by Google